Dr. Shrividya Iyer is a health care researcher currently working on cancer health outcomes research, with a key focus on both clinical drug development and public health outcomes for diverse tumor types and n parallel trying to apply evolving digital technology to optimize the collection and use of health care data evidence. She has a Ph.D. in pharmaceutical socioeconomics/outcomes research from the University of Iowa, USA, and a degree in pharmacy from the University of Mumbai, India. Currently, she is also part of an Executive Education program in Digital Health at the Columbia Business School, New York.
Dr. Iyer’s research focus over the last decade has been on understanding patient profiles and related clinical, economic, and patient-reported outcomes with cancer drugs/treatments both in clinical trials (for drugs in development) as well as post regulatory approval in clinical practice. Recent focus has evolved towards the application of technology to enable the integration of health care data with the goal of population/ public health outcomes evaluation at a global (multi-country/regional) level. Prior to that, she had been involved in research studies in other disease areas like cardiovascular, metabolic, and infectious diseases. Dr. Iyer has led global health economics/outcomes research teams within pharmaceutical companies and has presented extensively at professional conferences and published in leading peer-reviewed journals.
Dr. Iyer great proponent for STEM education and Women in Science and Health Care leadership positions, mentors students exploring various career paths within STEM.
Contact detail - https://www.linkedin.com/in/shrividya-iyer/
Happy learning!
Gargi